劲方医药-B(02595)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02595 劲方医药-B

未开盘 02-27 16:08:20

27.400

-0.280

-1.01%

最高28.840	最低27.400	成交量182.16万
今开27.680	昨收27.680	日振幅5.20%
总市值101.38亿	流通市值92.61亿	总股本3.70亿
成交额5,059万	换手率0.54%	流通股本3.38亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02595","market":"HK","secType":"STK","nameCN":"劲方医药-B","latestPrice":27.4,"timestamp":1772179700006,"preClose":27.68,"halted":0,"volume":1821600,"delay":0,"changeRate":-0.010115606936416227,"floatShares":338000000,"shares":370000000,"eps":-26.20482,"marketStatus":"未开盘","change":-0.28,"latestTime":"02-27 16:08:20","open":27.68,"high":28.84,"low":27.4,"amount":50586134,"amplitude":0.052023,"askPrice":27.52,"askSize":7000,"bidPrice":27.4,"bidSize":800,"shortable":3,"etf":0,"ttmEps":-2.744,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772415000000},"marketStatusCode":0,"adr":0,"listingDate":1758211200000,"exchange":"SEHK","adjPreClose":27.68,"openAndCloseTimeList":[[1772155800000,1772164800000],[1772168400000,1772179200000]],"volumeRatio":4.833148138099682,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02595","defaultTab":"news","newsList":[{"id":"2614038868","title":"每日卖空追踪 | 劲方医药-B 02月27日卖空量成交6.22万股，卖空比例为3.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614038868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614038868?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:30","pubTimestamp":1772181033,"startTime":"0","endTime":"0","summary":"劲方医药-B北京时间02月27日，跌1.01%，卖空量成交6.22万股，较上一交易日减少11.4%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163438a4367921&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163438a4367921&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02595","09939","BK1515","BK1161"],"gpt_icon":0},{"id":"2614012435","title":"劲方医药-B02月26日遭主力抛售2.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614012435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614012435?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:15","pubTimestamp":1772093734,"startTime":"0","endTime":"0","summary":"02月26日, 劲方医药-B股价跌1.35%，报收27.68元，成交金额656.6万元，换手率0.07%，振幅1.85%，量比0.51。劲方医药-B今日主力资金净流出2.1万元，上一交易日主力净流出130.8万元。该股近5个交易日下跌7.42%，主力资金累计净流出23.4万元；近20日主力资金累计净流出303.7万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226161746a4caa1d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226161746a4caa1d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","BK1161","09939","02595"],"gpt_icon":0},{"id":"2613571159","title":"劲方医药-B盘中异动 股价大跌5.09%报28.740港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613571159","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613571159?lang=zh_cn&edition=full","pubTime":"2026-02-24 13:02","pubTimestamp":1771909343,"startTime":"0","endTime":"0","summary":"2026年02月24日下午盘13时02分，劲方医药-B股票出现波动，股价快速下挫5.09%。截至发稿，该股报28.740港元/股，成交量13.0736万股，换手率0.04%，振幅4.56%。资金方面，该股资金流入112.399万港元，流出231.809万港元。劲方医药-B股票所在的药品行业中，整体跌幅为0.73%。其相关个股中，宝济药业-B、海西新药、君圣泰医药-B涨幅较大，振幅较大的相关个股有宝济药业-B、君圣泰医药-B、信达生物，振幅分别为10.61%、8.84%、7.17%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224130224a4c17795&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224130224a4c17795&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","BK1574","BK1161","09939","BK1515"],"gpt_icon":0},{"id":"2613731204","title":"每日卖空追踪 | 劲方医药-B 02月23日卖空量成交1.1万股，卖空比例为3.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613731204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613731204?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:30","pubTimestamp":1771835432,"startTime":"0","endTime":"0","summary":"劲方医药-B北京时间02月23日，涨5.43%，卖空量成交1.1万股，较上一交易日减少89.48%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163410a4be7dd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163410a4be7dd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02595","09939","BK1515","BK1161"],"gpt_icon":0},{"id":"2613205233","title":"劲方医药-B盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613205233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613205233?lang=zh_cn&edition=full","pubTime":"2026-02-23 10:24","pubTimestamp":1771813466,"startTime":"0","endTime":"0","summary":"2026年02月23日早盘10时24分，劲方医药-B股票出现波动，股价快速拉升5.01%。截至发稿，该股报30.160港元/股，成交量8.31万股，换手率0.02%，振幅6.48%。劲方医药-B股票所在的药品行业中，整体涨幅为0.79%。其相关个股中，中国同辐、九源基因、劲方医药-B涨幅较大，振幅较大的相关个股有泰德医药、精优药业、宝济药业-B，振幅分别为9.85%、8.33%、6.86%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223102426a4bda0ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223102426a4bda0ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","02595","BK1161","BK1574","BK1515"],"gpt_icon":0},{"id":"2613063293","title":"每日卖空追踪 | 劲方医药-B 02月20日卖空量成交5.36万股，卖空比例为9.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613063293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613063293?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:30","pubTimestamp":1771576231,"startTime":"0","endTime":"0","summary":"劲方医药-B北京时间02月20日，跌4.01%，卖空量成交5.36万股，较上一交易日减少41.23%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163418a70cd067&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220163418a70cd067&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","BK1161","02595","09939"],"gpt_icon":0},{"id":"2613293034","title":"劲方医药-B02月20日遭主力抛售34.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613293034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613293034?lang=zh_cn&edition=full","pubTime":"2026-02-20 16:15","pubTimestamp":1771575353,"startTime":"0","endTime":"0","summary":"02月20日, 劲方医药-B股价跌4.01%，报收28.72元，成交金额1555.8万元，换手率0.16%，振幅8.09%，量比0.97。劲方医药-B今日主力资金净流出34.8万元，上一交易日主力净流出173.6万元。该股近5个交易日下跌10.17%，主力资金累计净流出364.9万元；近20日主力资金累计净流入555.9万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220161925a4b5ddf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220161925a4b5ddf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","BK1574","BK1161","BK1515","09939"],"gpt_icon":0},{"id":"2611721771","title":"劲方医药-B盘中异动 早盘股价大涨7.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611721771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611721771?lang=zh_cn&edition=full","pubTime":"2026-02-16 09:33","pubTimestamp":1771205624,"startTime":"0","endTime":"0","summary":"2026年02月16日早盘09时33分，劲方医药-B股票出现波动，股价快速拉升7.08%。劲方医药-B股票所在的药品行业中，整体涨幅为0.07%。其相关个股中，英硅智能、康臣药业、海西新药涨幅较大，振幅较大的相关个股有海普瑞、英硅智能、复星医药，振幅分别为6.10%、5.78%、5.28%。劲方医药-B公司简介：劲方医药科技(上海)有限公司是一家专注于创新药物研发的中国公司。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021609334495413f0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021609334495413f0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1161","02595","BK1515","BK1574"],"gpt_icon":0},{"id":"2611514927","title":"劲方医药：KRAS G12D拟纳入突破疗法，二线治疗NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2611514927","media":"医药笔记","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611514927?lang=zh_cn&edition=full","pubTime":"2026-02-14 10:44","pubTimestamp":1771037097,"startTime":"0","endTime":"0","summary":"▎Armstrong2026年2月13日，劲方医药KRAS G12D抑制剂GFH375拟纳入突破治疗药物程序，用于至少接受过一种系统性治疗并具有KRAS G12D突变的非小细胞肺癌患者。GFH375为一款高选择性的强效KRAS G12D双重作用机制的抑制剂。GFH375在KRAS G12D的竞争格局中处于领先地位。去年8月，劲方医药披露了GFH375治疗NSCLC的1/2期临床数据。mPFS尚未达到，4个月PFS率超过75%。总结GFH375治疗NSCLC的疗效优异，与同类产品相比获得更优异的疗效数据，具有成为同类最佳的潜力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021411065197a628b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021411065197a628b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1515","02595","BK1574","BK1161"],"gpt_icon":0},{"id":"2611163851","title":"劲方医药-B(02595)获纳入恒生指数系列及MSCI指数成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2611163851","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611163851?lang=zh_cn&edition=full","pubTime":"2026-02-13 22:23","pubTimestamp":1770992625,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B 发布公告，依据恒生指数有限公司于2026年2月13日公布的恒生指数系列季度检讨结果，本公司入选恒生综合指数、恒生港股通指数以及恒生创新药指数等系列成分股。该调整将于2026年3月9日正式生效。此外，摩根士丹利资本国际指数近日宣布的季度审议结果显示，本公司亦将被纳入 MSCI全球小型股指数，该调整将于2026年2月27日收盘后生效。获纳入恒生综合指数，将令本公司股票符合资格于香港沪港通及深港通进行买卖。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405486.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"劲方医药-B(02595)获纳入恒生指数系列及MSCI指数成份股","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0511384066.AUD","LU0289960550.SGD","LU0289961442.SGD","LU2210150020.SGD","HHImain","02595","02833","BK4585","LU2210149790.SGD","MCHmain","LU2095319765.USD","BK1161","LU0708995401.HKD","LU0175139822.USD","BK4588","LU0289739343.SGD","BK1515","513600","LU0109391861.USD","LU0320765059.SGD","LU1804176565.USD","IE00BKPKM429.USD","LU1691799644.USD","LU1267930730.SGD","BK1574","BK4112","LU0672654240.SGD","LU2265009873.SGD","LU0390134368.USD"],"gpt_icon":0},{"id":"2611390978","title":"空池名单调整今日生效 劲方医药(02595)等51家公司进入新一期空池名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2611390978","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611390978?lang=zh_cn&edition=full","pubTime":"2026-02-13 07:17","pubTimestamp":1770938243,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港交所于2月10日修订了认可沽空指定证券名单，具体调整将于今日生效。根据港交所最新公告，国际商业结算、联合集团、硬蛋创新、亚洲金融、中国港能、非凡领越、嘉利国际、劲方医药、西普尼等51家公司加入新一期可进行卖空的指定证券名单。远东发展、思派健康、金地商置、傲基股份、广联科技控股、数字王国、浙江世宝、狮腾控股、威海银行、富力地产等31只股票从新一期可进行卖空的指定证券名单中删除。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404926.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1574","02777","BK1136","BK1161","159938","02595","09939","00662","BK1240","BK1555"],"gpt_icon":0},{"id":"2611690391","title":"劲方医药召开GFH375 III期注册性研究全国会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2611690391","media":"医药健闻","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611690391?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:09","pubTimestamp":1770883774,"startTime":"0","endTime":"0","summary":"劲方医药近日成功召开GFH375III期注册性研究的全国研究者会议。此项研究于2025年11月在首家中心启动，针对胰腺癌KRAS突变占比最高的G12D突变型患者开展，为全球首个口服KRAS G12D抑制剂的III期研究。来自全国的数十家研究中心专家代表齐聚北京，围绕项目的既往入组经验、治疗效果、以及后续项目管理进行深度交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212160946a6f27092&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212160946a6f27092&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02595","09939","BK1515"],"gpt_icon":0},{"id":"2611990399","title":"劲方医药-B盘中异动 早盘急速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611990399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611990399?lang=zh_cn&edition=full","pubTime":"2026-02-12 10:30","pubTimestamp":1770863458,"startTime":"0","endTime":"0","summary":"2026年02月12日早盘10时30分，劲方医药-B股票出现波动，股价大幅下挫5.00%。截至发稿，该股报30.020港元/股，成交量9.02万股，换手率0.03%，振幅5.57%。劲方医药-B股票所在的药品行业中，整体跌幅为0.09%。其相关个股中，恒瑞医药、宝济药业-B、联康生物科技集团涨幅较大，振幅较大的相关个股有开拓药业-B、劲方医药-B、四环医药，振幅分别为6.09%、5.57%、4.79%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212103058a6f14362&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212103058a6f14362&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","02595","BK1161","09939"],"gpt_icon":0},{"id":"2610659714","title":"劲方医药-B(02595.HK)：取消监事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2610659714","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610659714?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:47","pubTimestamp":1770648421,"startTime":"0","endTime":"0","summary":"格隆汇2月9日丨劲方医药-B(02595.HK)公告，股东于股东特别大会上通过特别决议案以批准取消监事会及修订组织章程细则。因此，自2026年2月9日起，公司将不再设有监事会，现任监事会成员不再担任监事；及经修订组织章程细则将自股东特别大会当日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260209/32008546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1515","BK1574","BK1161","159938","02595","09939"],"gpt_icon":0},{"id":"2610369169","title":"劲方医药-B02月09日主力净流入92.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2610369169","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610369169?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:15","pubTimestamp":1770624952,"startTime":"0","endTime":"0","summary":"02月09日, 劲方医药-B股价涨0.51%，报收31.58元，成交金额1299.0万元，换手率0.12%，振幅5.67%，量比0.72。劲方医药-B今日主力资金净流入92.9万元，上一交易日主力净流出0万元。该股近5个交易日上涨6.04%，主力资金累计净流入148.3万元；近20日主力资金累计净流入1575.4万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162308a6e53dd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162308a6e53dd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","09939","BK1161","02595"],"gpt_icon":0},{"id":"1185604739","title":"劲方医药科技（上海）（02595）更新2026年1月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1185604739","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185604739?lang=zh_cn&edition=full","pubTime":"2026-02-05 17:08","pubTimestamp":1770282516,"startTime":"0","endTime":"0","summary":"劲方医药科技（上海）股份有限公司于2026年2月5日披露截至2026年1月31日的股份变动月报表。报告期内，公司股本结构未发生变化，整体维持稳定。公司本月已发行股本总计为338,029,020股H股以及32,337,610股未上市股份，两类股份面值均为每股人民币0.1。各类股份数量较上月底保持一致。截至本月底，公司确认其已满足香港联交所对于最低公众持股量的要求。公告称，公司将继续遵守香港联交所《上市规则》等相关法规，持续保持股本结构和合规运营的透明度。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"2609327740","title":"交银国际：预计医药板块今年持续稳中向好 建议寻找被低估医药股","url":"https://stock-news.laohu8.com/highlight/detail?id=2609327740","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609327740?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:54","pubTimestamp":1770281655,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，恒生医疗保健指数本周累跌3.3%，表现跑输大市，去年第四季至今内资通过港股通持有医药股的比例亦出现轻微下降，外资持仓则有所提升，部分加仓创新药械及受惠于需求复苏的龙头CXO企业。在今年医药业务拓展中，交银国际建议关注小核酸、长效制剂、invivo CAR-T、新一代ADC/XDC等差异化平台，以及自免、代谢、CNS等疾病领域，认为该板块稳中向好的趋势将于今年延续，但仍有可能出现短期波动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402065.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000165453.HKD","02595","BK1574","09939","BK1583","03329","00013","BK1588","BK1593","BK1191","SG9999014674.SGD","02268","BK1515","BK1141","01530","BK1161","LU2488822045.USD","159938","BK1587","BK1147"],"gpt_icon":0},{"id":"2609969413","title":"劲方医药-B02月04日获主力加仓125.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609969413","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609969413?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:15","pubTimestamp":1770192941,"startTime":"0","endTime":"0","summary":"02月04日, 劲方医药-B股价涨7.33%，报收32.78元，成交金额3446.5万元，换手率0.32%，振幅8.97%，量比1.83。劲方医药-B今日主力资金净流入125.0万元，上一交易日主力净流入93.2万元。该股近5个交易日上涨7.06%，主力资金累计净流入7.0万元；近20日主力资金累计净流入1799.0万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161912a6d1f143&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161912a6d1f143&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","BK1161","09939","02595"],"gpt_icon":0},{"id":"2606205043","title":"劲方医药-B盘中异动 大幅上涨5.39%报30.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606205043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606205043?lang=zh_cn&edition=full","pubTime":"2026-01-27 10:37","pubTimestamp":1769481473,"startTime":"0","endTime":"0","summary":"2026年01月27日早盘10时37分，劲方医药-B股票出现异动，股价大幅上涨5.39%。截至发稿，该股报30.500港元/股，成交量41.26万股，换手率0.12%，振幅3.66%。资金方面，该股资金流入292.844万港元，流出62.9932万港元。劲方医药-B股票所在的药品行业中，整体跌幅为0.55%。其相关个股中，四环医药、兆科眼科-B、英硅智能涨幅较大，振幅较大的相关个股有四环医药、德琪医药-B、英硅智能，振幅分别为10.27%、8.05%、6.88%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127103753a6b0eb9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127103753a6b0eb9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","BK1574","BK1515","BK1161","09939"],"gpt_icon":0},{"id":"2606262291","title":"【券商聚焦】交银国际首予劲方医药(02595)买入评级 指其重点先行品种临床数据优势显著","url":"https://stock-news.laohu8.com/highlight/detail?id=2606262291","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606262291?lang=zh_cn&edition=full","pubTime":"2026-01-26 09:34","pubTimestamp":1769391259,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，劲方医药 建立了一条包括 6 款临床阶段候选药物的药物管线，并拥有RAS 产品候选矩阵，涵盖 KRAS G12C/G12D、泛 RAS 等细分赛道，及非降解类分子胶、功能性抗体协同偶联物等新型分子机制，其中 GFH925已在中国内地获批上市，为同靶点首款国产。未来12个月重点关注GFH925纳入医保后的销售放量节奏以及RAS管线更多PoC/I期数据读出。首次覆盖，给予买入评级。","market":"other","thumbnail":"https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973905","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","159938","09939"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genfleet.com","stockEarnings":[{"period":"1week","weight":-0.046},{"period":"1month","weight":-0.1046},{"period":"3month","weight":-0.044},{"period":"6month","weight":0.3438},{"period":"ytd","weight":0.1522}],"compareEarnings":[{"period":"1week","weight":0.0082},{"period":"1month","weight":-0.043},{"period":"3month","weight":0.0298},{"period":"6month","weight":0.0619},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.039}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"劲方医药科技（上海）有限公司是一家专注于创新药物研发的中国公司。该公司为肿瘤、自身免疫性疾病和炎症性疾病提供有效的新型治疗方案。该公司的研发平台涵盖靶点发现、分子发现与评估、转化科学和临床开发，以及制剂研究、工艺开发和质量分析等关键化学生产和控制环节。该公司主要致力于新分子类型和新药物模式的开发，分子工艺路线和质量标准的研究，以及差异化临床开发策略和路径的探索。该公司主要在中国国内和海外市场开展业务。","exchange":"SEHK","name":"劲方医药-B","nameEN":"GENFLEET-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"劲方医药-B(02595)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供劲方医药-B(02595)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"劲方医药-B,02595,劲方医药-B股票,劲方医药-B股票老虎,劲方医药-B股票老虎国际,劲方医药-B行情,劲方医药-B股票行情,劲方医药-B股价,劲方医药-B股市,劲方医药-B股票价格,劲方医药-B股票交易,劲方医药-B股票购买,劲方医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"劲方医药-B(02595)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供劲方医药-B(02595)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}